These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
76 related articles for article (PubMed ID: 2707527)
21. 5-ASA enema versus oral sulphasalazine in maintaining remission in ulcerative colitis. Andreoli A; Spinella S; Levenstein S; Prantera C Ital J Gastroenterol; 1994 Apr; 26(3):121-5. PubMed ID: 7914759 [TBL] [Abstract][Full Text] [Related]
22. Determination of the active moiety of BX661A, a new therapeutic agent for ulcerative colitis, by studying its therapeutic effects on ulcerative colitis induced by dextran sulfate sodium in rats. Kimura I; Kawasaki M; Nagahama S; Matsuda A; Kataoka M; Kokuba Y Arzneimittelforschung; 1998 Nov; 48(11):1091-6. PubMed ID: 9850431 [TBL] [Abstract][Full Text] [Related]
23. A prospective randomized controlled trial of oral ciprofloxacin in acute ulcerative colitis. Mantzaris GJ; Archavlis E; Christoforidis P; Kourtessas D; Amberiadis P; Florakis N; Petraki K; Spiliadi C; Triantafyllou G Am J Gastroenterol; 1997 Mar; 92(3):454-6. PubMed ID: 9068468 [TBL] [Abstract][Full Text] [Related]
24. Medical management of patients with difficult-to-treat inflammatory bowel disease. van Hogezand RA Neth J Med; 1994 Aug; 45(2):55-9. PubMed ID: 7936006 [TBL] [Abstract][Full Text] [Related]
26. A randomized, double blind, dose-response comparison of balsalazide (6.75 g), balsalazide (2.25 g), and mesalamine (2.4 g) in the treatment of active, mild-to-moderate ulcerative colitis. Levine DS; Riff DS; Pruitt R; Wruble L; Koval G; Sales D; Bell JK; Johnson LK Am J Gastroenterol; 2002 Jun; 97(6):1398-407. PubMed ID: 12094857 [TBL] [Abstract][Full Text] [Related]
27. Inhibition of DNA synthesis in human peripheral and lamina propria lymphocytes by 5-aminosalicylic acid and hydrocortisone. Elitsur Y; Freedland CP; Luk GD Reg Immunol; 1990; 3(1):56-61. PubMed ID: 2223557 [TBL] [Abstract][Full Text] [Related]
30. Combined therapy with 5-aminosalicylic acid tablets and enemas for maintaining remission in ulcerative colitis: a randomized double-blind study. d'Albasio G; Pacini F; Camarri E; Messori A; Trallori G; Bonanomi AG; Bardazzi G; Milla M; Ferrero S; Biagini M; Quaranta S; Amorosi A Am J Gastroenterol; 1997 Jul; 92(7):1143-7. PubMed ID: 9219787 [TBL] [Abstract][Full Text] [Related]
31. Mesalazine foam (Salofalk foam) in the treatment of active distal ulcerative colitis. A comparative trial vs Salofalk enema. The SAF-3 study group. Ardizzone S; Doldo P; Ranzi T; Sturniolo GC; Giglio LA; Annese V; D'Arienzo A; Gaia E; Gullini S; Riegler G; Valentini M; Massa P; Del Piano M; Rossini F; Guidetti CS; Pera A; Greinwald R; Bianchi Porro G Ital J Gastroenterol Hepatol; 1999 Nov; 31(8):677-84. PubMed ID: 10730559 [TBL] [Abstract][Full Text] [Related]
32. [Drug safety, acceptance and effectiveness of 5-aminosalicylic acid (mesalazine) in the treatment of ulcerative colitis and Crohn disease]. Bayerdörffer E; Bock H Leber Magen Darm; 1988 Apr; 18(2):104-13. PubMed ID: 3374251 [TBL] [Abstract][Full Text] [Related]
33. Sucralfate and hydrocortisone enemas in the treatment of active ulcerative proctitis--a randomized single-blind comparative study. Ardizzone S; Petrillo M; Antonacci CM; Bianchi Porro G Aliment Pharmacol Ther; 1996 Dec; 10(6):957-60. PubMed ID: 8971294 [TBL] [Abstract][Full Text] [Related]
34. Adverse effects of sulfasalazine and treatment of ulcerative colitis with mesalazine. Nakajima H; Munakata A; Yoshida Y J Gastroenterol; 1995 Nov; 30 Suppl 8():115-7. PubMed ID: 8563870 [TBL] [Abstract][Full Text] [Related]
35. Sucralfate and methylprednisolone enemas in active ulcerative colitis: a prospective, single-blind study. Wright JP; Winter TA; Candy S; Marks IS Dig Dis Sci; 1999 Sep; 44(9):1899-901. PubMed ID: 10505732 [TBL] [Abstract][Full Text] [Related]
36. Effect of glucocorticoids on rectal transport in normal subjects and patients with ulcerative colitis. Sandle GI; Hayslett JP; Binder HJ Gut; 1986 Mar; 27(3):309-16. PubMed ID: 3699552 [TBL] [Abstract][Full Text] [Related]
37. Evaluation of the application of enemas containing sucralfate in tissue content of neutral and acid mucins in experimental model of diversion colitis. Chaim FM; Sato DT; Rodrigues MR; Dias AM; Silveira Júnior PP; Pereira JA; Martinez CA Acta Cir Bras; 2014 Sep; 29(9):544-52. PubMed ID: 25252200 [TBL] [Abstract][Full Text] [Related]
38. Effect of sucralfate on experimental colitis in the rat. Zahavi I; Avidor I; Marcus H; Rosenbach Y; Waisman Y; Ligumsky M; Dinari G Dis Colon Rectum; 1989 Feb; 32(2):95-8. PubMed ID: 2914534 [TBL] [Abstract][Full Text] [Related]
39. Sucralfate enemas in ulcerative colitis. Winter TA; Marks IN Aliment Pharmacol Ther; 1997 Aug; 11(4):821-2. PubMed ID: 9305494 [No Abstract] [Full Text] [Related]
40. Short-chain fatty acid enemas: a cost-effective alternative in the treatment of nonspecific proctosigmoiditis. Senagore AJ; MacKeigan JM; Scheider M; Ebrom JS Dis Colon Rectum; 1992 Oct; 35(10):923-7. PubMed ID: 1395977 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]